Targeting androgen receptor-independent pathways in therapy-resistant prostate cancer
Since androgen receptor (AR) signaling is critically required for the development of prostate cancer (PCa), targeting AR axis has been the standard treatment of choice for advanced and metastatic PCa. Unfortunately, although the tumor initially responds to the therapy, treatment resistance eventuall...
Saved in:
| Main Authors: | Lingfan Xu, Junyi Chen, Weipeng Liu, Chaozhao Liang, Hailiang Hu, Jiaoti Huang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2019-01-01
|
| Series: | Asian Journal of Urology |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2214388218300900 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Posttranslational regulation of androgen dependent and independent androgen receptor activities in prostate cancer
by: Simeng Wen, et al.
Published: (2020-07-01) -
Intermittent androgen therapy in prostate cancer reveals the pro-apoptotic roles of androgen/androgen receptor: an overview
by: Saleh Altuwaijri, et al.
Published: (2025-03-01) -
Crosstalk between the Androgen Receptor and PPAR Gamma Signaling Pathways in the Prostate
by: Emuejevoke Olokpa, et al.
Published: (2017-01-01) -
Loss of androgen receptor-dependent growth suppression by prostate cancer cells can occur independently from acquiring oncogenic addiction to androgen receptor signaling.
by: Jason M D'Antonio, et al.
Published: (2010-07-01) -
Therapeutic targeting of the androgen receptor (AR) and AR variants in prostate cancer
by: Ramesh Narayanan
Published: (2020-07-01)